Cytokinetics, Incorporated (CYTK) Financials
CYTK Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 1.9 billion | 2.1 billion |
| March 31, 2026 | 1.3 billion | 2.1 billion |
| Dec. 31, 2025 | 1.4 billion | 2.1 billion |
| Sept. 30, 2025 | 1.4 billion | 2.0 billion |
CYTK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -164.2 million | 35.7 million |
| March 31, 2026 | -151.4 million | 30.4 million |
| Dec. 31, 2025 | -148.3 million | 30.5 million |
| Sept. 30, 2025 | -116.9 million | 30.7 million |
CYTK Net Income
No data available :(
CYTK Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 1.2 billion | 1.1 billion | 123.5 million |
| March 31, 2026 | 818.6 million | 1.1 billion | 126.2 million |
| Dec. 31, 2025 | 882.2 million | 1.1 billion | 127.1 million |
| Sept. 30, 2025 | 962.5 million | 1.0 billion | 131.3 million |
CYTK Shares Outstanding
CYTK Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 4.3 million | 97.8 million | 104.4 million | - |
| March 31, 2026 | 5.9 million | 95.5 million | 104.9 million | - |
| Dec. 31, 2025 | 5.6 million | 101.5 million | 91.7 million | - |
| Sept. 30, 2025 | 9.4 million | 99.2 million | 69.5 million | - |
CYTK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 31.9 million | 2.7 million |
| March 31, 2026 | 19.4 million | 2.4 million |
| Dec. 31, 2025 | 17.8 million | 2.9 million |
| Sept. 30, 2025 | 1.9 million | 2.7 million |
CYTK Revenue by Segment
Graph available only for paid members. Upgrade to see it.
CYTK
Price: $74.13
52 week price:
Earnings Per Share: -7.14 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 998300
Ebitda: -35.8 millionMarket Capitalization: 10.5 billion